S-Space

Browse

Author

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 181 to 240 of 339

Issue Date	Title / Author(s) / Citation	File
2016-10	Prognostic value of axillary nodal ratio after neoadjuvant chemotherapy of doxorubicin/cyclophosphamide followed by docetaxel in breast cancer: A multicenter retrospective cohort study Kim, Se Hyun; Jung, Kyung Hae; Kim, Tae-Yong; Im, Seock-Ah; Choi, In Sil; Chae, Yee Soo; Baek, Sun Kyung; Kang, Seok Yun; Park, Sarah; Park, In Hae; Lee, Keun Seok; Choi, Yoon Ji; Lee, Soohyeon; Sohn, Joo Hyuk; Park, Yeon-Hee; Im, Young-Hyuck; Ahn, Jin-Hee; Kim, Sung-Bae; Kim, Jee Hyun Cancer Research and Treatment, Vol.48 No.4, pp.1373-1381	DOI
2016-10	Outcome Analysis of Chemoradiation in Unresectable Pancreatic Cancer Focusing on Treatment Sequencing Strategy Koh, Hyeon Kang; Chie, Eui Kyu; Kim, Kyubo; Jang, Jin-Young; Kim, Sun Whe; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Ha, Sung W. Anticancer Research, Vol.36 No.10, pp.5455-5461	DOI
2016-10	Clinical and economic impact of pharmacists' intervention in a large volume chemotherapy preparation unit Han, Ji-Min; Ah, Young-Mi; Suh, Sung Yun; Jung, Sun-Hoi; Hahn, Hyeon Joo; Im, Seock-Ah; Lee, Ju-Yeun International Journal of Clinical Pharmacy, Vol.38 No.5, pp.1124-1132	DOI
2016-11	Soluble programmed death-ligand 1 (sPDL1) and neutrophil-to-lymphocyte ratio (NLR) predicts survival in advanced biliary tract cancer patients treated with palliative chemotherapy Ha, Hyerim; Nam, Ah-Rong; Bang, Ju-Hee; Park, Ji-Eun; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Oh, Do-Youn Oncotarget, Vol.7 No.47, pp.76604-76612	DOI
2016-11	Palbociclib and Letrozole in Advanced Breast Cancer Finn, Richard S.; Martin, Miguel; Rugo, Hope S.; Jones, Stephen; Im, Seock-Ah; Gelmon, Karen; Harbeck, Nadia; Lipatov, Oleg N.; Walshe, Janice M.; Moulder, Stacy; Gauthier, Eric; Lu, Dongrui R.; Randolph, Sophia; Dieras, Veronique; Slamon, Dennis J. New England Journal of Medicine, Vol.375 No.20, pp.1925-1936	DOI
2016-11	Pretreatment MR Imaging Features of Triple-Negative Breast Cancer: Association with Response to Neoadjuvant Chemotherapy and Recurrence-Free Survival Bae, Min Sun; Shin, Sung Ui; Ryu, Han Suk; Han, Wonshik; Im, Seock-Ah; Park, In-Ae; Noh, Dong-Young; Moon, Woo Kyung Radiology, Vol.281 No.2, pp.392-400	DOI
2016-12	Clonal evolutionary analysis during HER2 blockade in HER2-positive inflammatory breast cancer: A phase II open-label clinical trial of afatinib plus /- vinorelbine Goh, Gerald; Schmid, Ramona; Guiver, Kelly; Arpornwirat, Wichit; Chitapanarux, Imjai; Ganju, Vinod; Im, Seock-Ah; Kim, Sung-Bae; Dechaphunkul, Arunee; Maneechavakajorn, Jedzada; Spector, Neil; Yau, Thomas; Afrit, Mehdi; Ben Ahmed, Slim; Johnston, Stephen R.; Gibson, Neil; Uttenreuther-Fischer, Martina; Herrero, Javier; Swanton, Charles PLoS Medicine, Vol.13 No.12, p. e1002136	DOI
2016-12	Prognostic Significance of Inner Quadrant Involvement in Breast Cancer Treated with Neoadjuvant Chemotherapy Chang, Ji Hyun; Jeon, Wan; Kim, Kyubo; Shin, Kyung Hwan; Han, Wonshik; Noh, Dong-Young; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue Journal of Breast Cancer, Vol.19 No.4, pp.394-401	DOI
2016-12	Accelerated whole breast irradiation in early breast cancer patients with adverse prognostic features Lee, Sea-Won; Shin, Kyung Hwan; Chie, Eui Kyu; Kim, Jin Ho; Im, Seock-Ah; Han, Wonshik; Noh, Dong-Young; Lim, Hyeon Woo; Kim, Tae Hyun; Lee, Keun Seok; Lee, Eun Sook; Sung, Soo Yoon; Kim, Kyubo Oncotarget, Vol.7 No.49, pp.81888-81898	DOI
2017-01	Anti-tumor activity of the ATR inhibitor AZD6738 in HER2 positive breast cancer cells Kim, Hee-Jun; Min, Ahrum; Im, Seock-Ah; Jang, Hyemin; Lee, Kyung Hun; Lau, Alan; Lee, Miso; Kim, Seongyeong; Yang, Yaewon; Kim, Jungeun; Kim, Tae Yong; Oh, Do-Youn; Brown, Jeffrey; O'Connor, Mark J.; Bang, Yung-Jue International Journal of Cancer, Vol.140 No.1, pp.109-119	DOI
2017-01	Signature of cytokines and angiogenic factors (CAFs) defines a clinically distinct subgroup of gastric cancer Ock, Chan-Young; Nam, Ah-Rong; Bang, Ju-Hee; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Oh, Do-Youn Gastric Cancer, Vol.20 No.1, pp.164-174	DOI
2017-01	Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and their dynamic changes during chemotherapy is useful to predict a more accurate prognosis of advanced biliary tract cancer Cho, Kyoung-Min; Park, Hyunkyung; Oh, Do-Youn; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue Oncotarget, Vol.8 No.2, pp.2329-2341	DOI
2017-03	Prognostic implication of antitumor immunity measured by the neutrophil-lymphocyte ratio and serum cytokines and angiogenic factors in gastric cancer Ock, Chan-Young; Nam, Ah-Rong; Lee, Joongyub; Bang, Ju-Hee; Lee, Kyung-Hun; Han, Sae-Won; Kim, Tae-Yong; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Oh, Do-Youn Gastric Cancer, Vol.20 No.2, pp.254-262	DOI
2017-03	Optimal Timing of Influenza Vaccination During 3-Week Cytotoxic Chemotherapy Cycles Keam, Bhumsuk; Kim, Min-Kyung; Choi, Yunhee; Choi, Su-Jin; Choe, Pyoeng Gyun; Lee, Kyung-Hun; Kim, Tae Min; Kim, Tae-Yong; Oh, Do-Youn; Kim, Dong-Wan; Im, Seock-Ah; Kim, Nam-Joong; Heo, Dae Seog; Park, Wan Beom; Oh, Myoung-don Cancer, Vol.123 No.5, pp.841-848	DOI
2017-04	Feasibility and Efficacy of Eribulin Mesilate in Korean Patients with Metastatic Breast Cancer: Korean Multi-center Phase IV Clinical Study Results Park, Yeon Hee; Kim, Tae Yong; Im, Young-Hyuck; Lee, Keun-Seok; Park, In Hae; Sohn, Joohyuk; Lee, Soo-Hyeon; Im, Seock-Ah; Kim, Jee Hyun; Kim, Se Hyun; Lee, Soo Jung; Koh, Su-Jin; Lee, Ki Hyeong; Choi, Yoon Ji; Cho, Eun Kyung; Lee, Suee; Kang, Seok Yun; Seo, Jae Hong; Kim, Sung-Bae; Jung, Kyung Hae Cancer Research and Treatment, Vol.49 No.2, pp.423-429	DOI
2017-04	Efficacy of Letrozole as First-Line Treatment of Postmenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer in Korea Beom, Seung Hoon; Oh, Jisu; Kim, Tae-Yong; Lee, Kyung-Hun; Yang, Yaewon; Suh, Koung Jin; Moon, Hyeong-Gon; Han, Sae-Won; Oh, Do-Youn; Han, Wonshik; Kim, Tae-You; Noh, Dong-Young; Im, Seock-Ah Cancer Research and Treatment, Vol.49 No.2, pp.454-463	DOI
2017-04	Efficacy and Safety of Regorafenib in Korean Patients with Advanced Gastrointestinal Stromal Tumor after Failure of lmatinib and Sunitinib: A Multicenter Study Based on the Management Access Program Son, Myoung Kyun; Ryu, Min-Hee; Park, Joon Oh; Im, Seock-Ah; Kim, Tae-Yong; Lee, Su Jin; Ryoo, Baek-Yeol; Park, Sook Ryun; Kang, Yoon-Koo Cancer Research and Treatment, Vol.49 No.2, pp.350-357	DOI
2017-05	Health-related quality of life in patients with locally recurrent or metastatic breast cancer treated with etirinotecan pegol versus treatment of physician's choice: Results from the randomised phase III BEACON trial Twelves, Chris; Cortes, Javier; O'Shaughnessy, Joyce; Awada, Ahmad; Perez, Edith A.; Im, Seock-Ah; Gomez-Pardo, Patricia; Schwartzberg, Lee S.; Dieras, Veronique; Yardley, Denise A.; Potter, David A.; Mailliez, Audrey; Moreno-Aspitia, Alvaro; Ahn, Jin-Seok; Zhao, Carol; Hoch, Ute; Tagliaferri, Mary; Hannah, Alison L.; Rugo, Hope S. European Journal of Cancer, Vol.76, pp.205-215	DOI
2017-06	Phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach Kurokawa, Yukinori; Yang, Han-Kwang; Cho, Haruhiko; Ryu, Min-Hee; Masuzawa, Toru; Park, Sook Ryun; Matsumoto, Sohei; Lee, Hyuk-Joon; Honda, Hiroshi; Kwon, Oh Kyoung; Ishikawa, Takashi; Lee, Kyung Hee; Nabeshima, Kazuhito; Kong, Seong-Ho; Shimokawa, Toshio; Yook, Jeong-Hwan; Doki, Yuichiro; Im, Seock-Ah; Hirota, Seiichi; Hahn, Seokyung; Nishida, Toshirou; Kang, Yoon-Koo British Journal of Cancer, Vol.117 No.1, pp.25-32	DOI
2017-07	Antitumor Effect of KX-01 through Inhibiting Src Family Kinases and Mitosis Kim, Seongyeong; Min, Ahrum; Lee, Kyung-Hun; Yang, Yaewon; Kim, Tae-Yong; Lim, Jee Min; Park, So Jung; Nam, Hyun-Jin; Kim, Jung Eun; Song, Sang-Hyun; Han, Sae-Won; Oh, Do-Youn; Kim, Jee Hyun; Kim, Tae-You; Hangauer, David; Lau, Johnson Yiu-Nam; Im, Kyongok; Lee, Dong Soon; Bang, Yung-Jue; Im, Seock-Ah Cancer Research and Treatment, Vol.49 No.3, pp.643-655	DOI
2017-07	CA19-9 or CEA Decline after the First Cycle of Treatment Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with S-1 and Cisplatin Chemotherapy Lee, Dae-Won; Im, Seock-Ah; Kim, Yu Jung; Yang, Yaewon; Rhee, Jiyoung; Na, Im Ii; Lee, Kyung-Hun; Kim, Tae -Yong; Han, Sae -Won; Choi, In Sil; Oh, Do-Youn; Kim, Jee Hyun; Kim, Tae -You; Bang, Yung-Jue Cancer Research and Treatment, Vol.49 No.3, pp.807-815	DOI
2017-07	Incidence of taxane-induced peripheral neuropathy receiving treatment and prescription patterns in patients with breast cancer Song, Su Jeong; Min, Ji; Suh, Sung Yun; Jung, Sun Hoi; Hahn, Hyeon Joo; Im, Seock-Ah; Lee, Ju-Yeun Supportive Care in Cancer, Vol.25 No.7, pp.2241-2248	DOI
2017-08	Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation Robson, Mark; Im, Seock-Ah; Senkus, Elzbieta; Xu, Binghe; Domchek, Susan M.; Masuda, Norikazu; Delaloge, Suzette; Li, Wei; Tung, Nadine; Armstrong, Anne; Wu, Wenting; Goessl, Carsten; Runswick, Sarah; Conte, Pierfranco New England Journal of Medicine, Vol.377 No.6, pp.523-533	DOI
2017-08	PALOMA-3: Phase III Trial of Fulvestrant With or Without Palbociclib in Premenopausal and Postmenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That Progressed on Prior Endocrine Therapy-Safety and Efficacy in Asian Patients Iwata, Hiroji; Im, Seock-Ah; Masuda, Norikazu; Im, Young-Hyuck; Inoue, Kenichi; Rai, Yoshiaki; Nakamura, Rikiya; Kim, Jee Hyun; Hoffman, Justin T.; Zhang, Ke; Giorgetti, Carla; Lyer, Shrividya; Schnell, Patrick T.; Bartlett, Cynthia Huang; Ro, Jungsil Journal of Global Oncology, Vol.3 No.4, pp.289-303	DOI
2017-09	EGFR or HER2 inhibition modulates the tumor microenvironment by suppression of PD-L1 and cytokines release Suh, Koung Jin; Sung, Ji Hea; Kim, Jin Won; Han, Song-Hee; Lee, Hye Seung; Min, Ahrum; Kang, Mi Hyun; Kim, Ji Eun; Kim, Ji-Won; Kim, Se Hyun; Lee, Jeong-Ok; Kim, Yu Jung; Lee, Keun-Wook; Kim, Jee Hyun; Bang, Soo-Mee; Im, Seock-Ah; Lee, Jong Seok Oncotarget, Vol.8 No.38, pp.63901-63910	DOI
2017-09	Palbociclib Combined with Fulvestrant in Premenopausal Women with Advanced Breast Cancer and Prior Progression on Endocrine Therapy: PALOMA-3 Results Loibl, Sibylle; Turner, Nicholas C.; Ro, Jungsil; Cristofanilli, Massimo; Iwata, Hiroji; Im, Seock-Ah; Masuda, Norikazu; Loi, Sherene; Andre, Fabrice; Harbeck, Nadia; Verma, Sunil; Folkerd, Elizabeth; Theall, Kathy Puyana; Hoffman, Justin; Zhang, Ke; Bartlett, Cynthia Huang; Dowsett, Mitchell Oncologist, Vol.22 No.9, pp.1028-1038	DOI
2017-10	Korean Cancer Patients' Awareness of Clinical Trials, Perceptions on the Benefit and Willingness to Participate Lim, Yoojoo; Lim, Jee Min; Jeong, Won Jae; Lee, Kyung-Hun; Keam, Bhumsuk; Kim, Tae-Yong; Kim, Tae Min; Han, Sae-Won; Oh, Do Youn; Kim, Dong-Wan; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue; Im, Seock-Ah Cancer Research and Treatment, Vol.49 No.4, pp.1033-1043	view file DOI
2017-10	Bilateral Salpingo-oophorectomy Compared to Gonadotropin-Releasing Hormone Agonists in Premenopausal Hormone Receptor-Positive Metastatic Breast Cancer Patients Treated with Aromatase Inhibitors Suh, Koung Jin; Kim, Se Hyun; Lee, Kyung-Hun; Kim, Tae-Yong; Kim, Yu Jung; Han, Sae-Won; Kang, Eunyoung; Kim, Eun-Kyu; Kim, Kidong; No, Jae Hong; Han, Wonshik; Noh, Dong-Young; Lee, Maria; Kim, Hee Seung; Im, Seock-Ah; Kim, Jee Hyun Cancer Research and Treatment, Vol.49 No.4, pp.1153-1163	DOI
2017-10	Skeletal muscle depletion predicts survival of patients with advanced biliary tract cancer undergoing palliative chemotherapy Cho, Kyoung-Min; Park, Hyunkyung; Oh, Do-Youn; Kim, Tae-Yong; Lee, Kyung Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue Oncotarget, Vol.8 No.45, pp.79441-79452	DOI
2017-12	Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial ExteNET Study Group; Im, Seock Ah The Lancet Oncology, Vol.18 No.12, pp.1688-1700	DOI
2017-12	Cyclophosphamide, Methotrexate, and 5-Fluorouracil as Palliative Treatment for Heavily Pretreated Patients with Metastatic Breast Cancer: A Multicenter Retrospective Analysis Park, Jin Hyun; Im, Seock-Ah; Byun, Ja Min; Kim, Ki Hwan; Kim, Jin-Soo; Choi, In Sil; Kim, Hee-Jun; Lee, Kyung-Hun; Kim, Tae-Yong; Han, Sae-Won; Oh, Do Youn; Kim, Tae-You Journal of Breast Cancer, Vol.20 No.4, pp.347-355	DOI
2018-03	Phase III, Randomized study of dual human epidermal growth factor receptor 2 (HER2) blockade with lapatinib plus trastuzumab in combination with an aromatase inhibitor in postmenopausal women with HER2-positive, hormone receptor-positive metastatic breast cancer: ALTERNATIVE Johnston, Stephen R. D.; Hegg, Roberto; Im, Seock-Ah; Park, In Hae; Burdaeva, Olga; Kurteva, Galina; Press, Michael F.; Tjulandin, Sergei; Iwata, Hiroji; Simon, Sergio D.; Kenny, Sarah; Sarp, Severine; Izquierdo, Miguel A.; Williams, Lisa S.; Gradishar, William J. Journal of Clinical Oncology, Vol.36 No.8, pp.741-748	DOI
2018-04	A phase III study comparing SB3 (a proposed trastuzumab biosimilar) and trastuzumab reference product in HER2-positive early breast cancer treated with neoadjuvant-adjuvant treatment: Final safety, immunogenicity and survival results Pivot, X.; Bondarenko, I.; Nowecki, Z.; Dvorkin, M.; Trishkina, E.; Ahn, J. H.; Im, S. A.; Sarosiek, T.; Chatterjee, S.; Wojtukiewicz, M. Z.; Shparyk, Y.; Moiseyenko, V.; Bello, M., III; Semiglazov, V.; Lee, Y.; Lim, J. European Journal of Cancer, Vol.93, pp.19-27	DOI
2018-05	Cyclin E overexpression confers resistance to the CDK4/6 specific inhibitor palbociclib in gastric cancer cells Min, Ahrum; Kim, Jung Eun; Kim, Yu-Jin; Lim, Jee Min; Kim, Seongyeong; Kim, Jin Won; Lee, Kyung-Hun; Kim, Tae-Yong; Oh, Do-Youn; Bang, Yung-Jue; Im, Seock-Ah Cancer Letters, Vol.430, pp.123-132	DOI
2018-07	Change in topoisomerase 1–positive circulating tumor cells affects overall survival in patients with advanced breast cancer after treatment with etirinotecan pegol Rugo, Hope S.; Cortes, Javier; Awada, Ahmad; O'Shaughnessy, Joyce; Twelves, Chris; Im, Seock-Ah; Hannah, Alison; Lu, Lin; Sy, Sherwin; Caygill, Katie; Zajchowski, Deborah A.; Davis, Darren W.; Tagliaferri, Mary; Hoch, Ute; Perez, Edith A. Clinical Cancer Research, Vol.24 No.14, pp.3348-3357	DOI
2018-08	Phase III randomized study of ribociclib and fulvestrant in hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: MONALEESA-3 Slamon, Dennis J.; Neven, Patrick; Chia, Stephen; Fasching, Peter A.; De Laurentiis, Michelino; Im, Seock-Ah; Petrakova, Katarina; Bianchi, Giulia Val; Esteva, Francisco J.; Martin, Miguel; Nusch, Arnd; Sonke, Gabe S.; De la Cruz-Merino, Luis; Beck, J. Thaddeus; Pivot, Xavier; Vidam, Gena; Wang, Yingbo; Lorenc, Karen Rodriguez; Miller, Michelle; Taran, Tetiana; Jerusalem, Guy Journal of Clinical Oncology, Vol.36 No.24, pp.2465-2472	DOI
2018-11	Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer Schmid, P.; Adams, S.; Rugo, H. S.; Schneeweiss, A.; Barrios, C. H.; Iwata, H.; Dieras, V.; Hegg, R.; Im, S. -A.; Wright, G. Shaw; Henschel, V.; Molinero, L.; Chui, S. Y.; Funke, R.; Husain, A.; Winer, E. P.; Loi, S.; Emens, L. A. New England Journal of Medicine, Vol.379 No.22, pp.2108-2121	DOI
2018-11	Buparlisib plus fulvestrant versus placebo plus fulvestrant for postmenopausal, hormone receptor-positive, human epidermal growth factor receptor 2-negative, advanced breast cancer: Overall survival results from BELLE-2 Campone, Mario; Im, Seock-Ah; Iwata, Hiroji; Clemons, Mark; Ito, Yoshinori; Awada, Ahmad; Chia, Stephen; Jagiello-Gruszfeld, Agnieszka; Pistilli, Barbara; Tseng, Ling-Ming; Hurvitz, Sara; Masuda, Norikazu; Cortes, Javier; De Laurentiis, Michele; Arteaga, Carlos L.; Jiang, Zefei; Jonat, Walter; Le Mouhaer, Sylvie; Sankaran, Banu; Bourdeau, Laurence; El-Hashimy, Mona; Sellami, Dalila; Baselga, Jose European Journal of Cancer, Vol.103, pp.147-154	DOI
2018-11	Predictors of prolonged benefit from palbociclib plus fulvestrant in women with endocrine-resistant hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer in PALOMA-3 Cristofanilli, Massimo; DeMichele, Angela; Giorgetti, Carla; Turner, Nicholas C.; Slamon, Dennis J.; Im, Seock-Ah; Masuda, Norikazu; Verma, Shailendra; Loi, Sherene; Colleoni, Marco; Theall, Kathy Puyana; Huang, Xin; Liu, Yuan; Bartlett, Cynthia Huang European Journal of Cancer, Vol.104, pp.21-31	DOI
2018-11	Overall survival with palbociclib and fulvestrant in advanced breast cancer Turner, Nicholas C.; Slamon, Dennis J.; Ro, Jungsil; Bondarenko, Igor; Im, Seock-Ah; Masuda, Norikazu; Colleoni, Marco; DeMichele, Angela; Loi, Sherene; Verma, Sunil; Iwata, Hiroji; Harbeck, Nadia; Loibl, Sibylle; Andre, Fabrice; Theall, K. Puyana; Huang, Xin; Giorgetti, Carla; Bartlett, C. Huang; Cristofanilli, Massimo New England Journal of Medicine, Vol.379 No.20, pp.1926-1936	DOI
2018-12	A phase II trial of the pan-HER inhibitor poziotinib, in patients with HER2-positive metastatic breast cancer who had received at least two prior HER2-directed regimens: results of the NOV120101-203 trial Park, Yeon Hee; Lee, Kyung-Hun; Sohn, Joo Hyuk; Lee, Keun Seok; Jung, Kyung Hae; Kim, Jee-Hyun; Lee, Ki Hyeong; Ahn, Jin Seok; Kim, Tae-Yong; Kim, Gun Min; Park, In Hae; Kim, Sung-Bae; Kim, Se Hyun; Han, Hye Sook; Im, Young-Hyuck; Ahn, Jin-Hee; Kim, Jung-Yong; Kang, Jahoon; Im, Seock-Ah International Journal of Cancer, Vol.143 No.12, pp.3240-3247	DOI
2018-12	nCirculating biomarkers and resistance to endocrine therapy in metastatic breast cancers: Correlative results from AZD9496 oral SERD phase I trial Paoletti, Costanza; Schiavon, Gaia; Dolce, Emily M.; Darga, Elizabeth P.; Carr, T. Hedley; Geradts, Joseph; Hoch, Matthias; Klinowska, Teresa; Lindemann, Justin; Marshall, Gayle; Morgan, Shethah; Patel, Parul; Rowlands, Vicky; Sathiyayogan, Nitharsan; Aung, Kimberly; Hamilton, Erika; Patel, Manish; Armstrong, Anne; Jhaveri, Komal; Im, Seock-Ah; Iqbal, Nadia; Butt, Fouziah; Dive, Caroline; Harrington, Elizabeth A.; Barrett, J. Carl; Baird, Richard; Hayes, Daniel F. Clinical Cancer Research, Vol.24 No.23, pp.5860-5872	DOI
2019-01	Landscape of actionable genetic alterations profiled from 1,071 tumor samples in Korean cancer patients Lee, Se-Hoon; Lee, Boram; Shim, Joon Ho; Lee, Kwang Woo; Yun, Jae Won; Kim, Sook-Young; Kim, Tae-You; Kim, Yeul Hong; Ko, Young Hyeh; Chung, Hyun Cheol; Yu, Chang Sik; Lee, Jeeyun; Rha, Sun Young; Kim, Tae Won; Jung, Kyung Hae; Im, Seock-Ah; Moon, Hyeong-Gon; Cho, Sukki; Kang, Jin Hyoung; Kim, Jihun; Kim, Sang Kyum; Ryu, Han Suk; Ha, Sang Yun; Kim, Jong Il; Chung, Yeun-Jun; Kim, Cheolmin; Kim, Hyung-Lae; Park, Woong-Yang; Noh, Dong-Young; Park, Keunchil Cancer Research and Treatment, Vol.51 No.1, pp.211-222	DOI
2019-01	Randomized Open Labe Phase III Trial of Irinotecan Plus Capecitabine versus Capecitabine Monotherapy in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01) Park, In Hae; Im, Seock-Ah; Jung, Kyung Hae; Sohn, Joo Hyuk; Park, Yeon Hee; Lee, Keun Seok; Sim, Sung Hoon; Park, Kyong-Hwa; Kim, Jee Hyun; Nam, Byung Ho; Kim, Hee-Jun; Kim, Tae-Yong; Lee, Kyung-Hun; Kim, Sung-Bae; Ahn, Jin-Hee; Lee, Suee; Ro, Jungsil Cancer Research and Treatment, Vol.51 No.1, pp.43-52	DOI
2019-04	Pan-PIM kinase inhibitor AZD1208 suppresses tumor growth and synergistically interacts with AKT inhibition in gastric cancer cells Lee, Miso; Lee, Kyung-Hun; Min, Ahrum; Kim, Jeongeun; Kim, Seongyeong; Jang, Hyemin; Lim, Jee Min; Kim, So Hyeon; Ha, Dong-Hyeon; Jeong, Won Jae; Suh, Koung Jin; Yang, Yae-Won; Kim, Tae Yong; Oh, Do-Youn; Bang, Yung-Jue; Im, Seock-Ah Cancer Research and Treatment, Vol.51 No.2, pp.451-463	DOI
2019-05	Quality of life outcomes including neuropathy-associated scale from a phase II, multicenter, randomized trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy for HER2-negative metastatic breast cancer: Korean Cancer Study Group Trial (KCSG BR13-11) Kim, Ji-Yeon; Park, Seri; Im, Seock-Ah; Kim, Sung-Bae; Sohn, Joohyuk; Lee, Keun Seok; Chae, Yee Soo; Lee, Ki Hyeong; Kim, Jee Hyun; Im, Young-Hyuck; Kim, Tae-Yong; Lee, Kyung-Hun; Ahn, Jin-Hee; Kim, Gun Min; Park, In Hae; Lee, Soo Jung; Han, Hye Sook; Kim, Se Hyun; Jung, Kyung Hae; Park, Yeon Hee Cancer Communications, Vol.39 No.1, pp.1-8	view file DOI
2019-05	Palbociclib plus letrozole as first-line therapy in postmenopausal Asian women with metastatic breast cancer: Results from the phase III, randomized PALOMA-2 study Im, Seock-Ah; Mukai, Hirofumi; Park, In Hae; Masuda, Norikazu; Shimizu, Chikako; Kim, Sung-Bae; Im, Young-Hyuck; Ohtani, Shoichiro; Bartlett, Cynthia Huang; Lu, Dongrui R.; Iyer, Shrividya; Mori, Yuko; Mori, Ave; Gauthier, Eric; Finn, Richard S.; Toi, Masakazu Journal of Global Oncology, Vol.2019 No.5, pp.1-19	DOI
2019-06	Challenges and insights of early oncology drug development in the Asia-Pacific region: introduction of phase I oncology clinical trial center and experience sharing for early clinical trials in Seoul National University Hospital, Korea Im, Seock-Ah; Lee, Dae-Won; Kang, Ryungwoo; Kim, Jee Hyun; Kim, Dong-Wan; Jang, In-Jin; Lee, Jong-Seok; Bang, Yung-Jue Chinese Clinical Oncology, Vol.8 No.3, p. 27	view file DOI
2019-07	Overall survival with ribociclib plus endocrine therapy in breast cancer Im, Seock-Ah; Lu, Yen-Shen; Bardia, Aditya; Harbeck, Nadia; Colleoni, Marco; Franke, Fabio; Chow, Louis; Sohn, Joohyuk; Lee, Keun-Seok; Campos-Gomez, Saul; Villanueva-Vazquez, Rafael; Jung, Kyung-Hae; Chakravartty, Arunava; Hughes, Gareth; Gounaris, Ioannis; Rodriguez-Lorenc, Karen; Taran, Tetiana; Hurvitz, Sara; Tripathy, Debu New England Journal of Medicine, Vol.381 No.4, pp.307-316	DOI
2019-07	Prognostic role of body mass index is different according to menopausal status and tumor subtype in breast cancer patients Kim, Jung Youn; Lee, Dae-Won; Lee, Kyung-Hun; Min, Ahrum; Ryu, Han Suk; Lee, Han-Byoel; Moon, Hyeong-Gon; Kim, Tae-Yong; Han, Sae-Won; Oh, Do-Youn; Han, Wonshik; Park, In Ae; Noh, Dong-Young; Im, Seock-Ah; Kim, Sukil Breast Cancer Research and Treatment, Vol.176 No.2, pp.453-460	DOI
2019-09	Molecular alterations and poziotinib efficacy, a pan-HER inhibitor, in human epidermal growth factor receptor 2 (HER2)-positive breast cancers: Combined exploratory biomarker analysis from a phase II clinical trial of poziotinib for refractory HER2-positive breast cancer patients Kim, Ji-Yeon; Lee, Eunjin; Park, Kyunghee; Jung, Hae Hyun; Park, Woong-Yang; Lee, Kyung-Hun; Sohn, Joohyuk; Lee, Keun Seok; Jung, Kyung Hae; Kim, Jee Hyun; Lee, Ki Hyeong; Im, Seock-Ah; Park, Yeon Hee International Journal of Cancer, Vol.145 No.6, pp.1669-1678	DOI
2019-09	성인 고형암 환자의 고칼슘혈증 치료현황과 치료효과 분석 신다은; 박설희; 김성환; 서성연; 조윤희; 조윤숙; 임석아; 이주연 한국임상약학회지, Vol.29 No.3, pp.166-172	DOI
2019-10	The HER2 S310F Mutant Can Form an Active Heterodimer with the EGFR, Which Can Be Inhibited by Cetuximab but Not by Trastuzumab as well as Pertuzumab Shin, Jung Won; Kim, Soohyun; Ha, Suji; Choi, Byungsan; Kim, Seongyeong; Im, Seock-Ah; Yoon, Tae-Young; Chung, Junho Biomolecules, Vol.9 No.10, p. 629	DOI
2019-10	Ribociclib and Endocrine Therapy in Breast Cancer REPLY Im, Seock-Ah; Lu, Yen-Shen; Tripathy, Debu New England Journal of Medicine, Vol.381 No.16, pp.1592-1593	DOI
2019-10	Patient-reported outcomes in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer receiving olaparib versus chemotherapy in the OlympiAD trial Robson, Mark; Ruddy, Kathryn J.; Im, Seock-Ah; Senkus, Elzbieta; Xu, Binghe; Domchek, Susan M.; Masuda, Norikazu; Li, Wei; Tung, Nadine; Armstrong, Anne; Delaloge, Suzette; Bannister, Wendy; Goessl, Carsten; Degboe, Arnold; Hettle, Robert; Conte, Pierfranco European Journal of Cancer, Vol.120, pp.20-30	DOI
2019-12	Prognostic Impact of Pregnancy in Korean Patients with Breast Cancer Choi, Mihong; Han, Jiyeon; Yang, Bo Ram; Jang, Myoung-jin; Kim, Miso; Kim, Tae-Yong; Im, Seock-Ah; Lee, Han-Byoel; Moon, Hyeong-Gon; Han, Wonshik; Noh, Dong-Young; Lee, Kyung-Hun Oncologist, Vol.24 No.12, pp.e1268-e1276	DOI
2019-12	Randomised Phase 2 study of lapatinib and vinorelbine vs vinorelbine in patients with HER2+metastatic breast cancer after lapatinib and trastuzumab treatment (KCSG BR11-16) Sim, Sung Hoon; Park, In Hae; Jung, Kyung Hae; Kim, Sung-Bae; Ahn, Jin-Hee; Lee, Kyung-Hun; Im, Seock-Ah; Im, Young-Hyuck; Park, Yeon Hee; Sohn, Joohyuk; Kim, Yu Jung; Lee, Suee; Kim, Hee-Jun; Chae, Yee Soo; Park, Kyong Hwa; Nam, Byung-Ho; Lee, Keun Seok; Ro, Jungsil British Journal of Cancer, Vol.121 No.12, pp.985-990	DOI
2019-12	Amenorrhea and menopause in patients with breast cancer after chemotherapy Shin, Jae Jun; Choi, Young Min; Jun, Jong Kwan; Lee, Kyung-Hun; Kim, Tae-Yong; Han, Wonshik; Im, Seock-Ah Journal of Breast Cancer, Vol.22 No.4, pp.624-634	DOI
2020-02	Survival outcomes of breast cancer patients with brain metastases: A multicenter retrospective study in Korea (KROG 16-12) Kim, Jae Sik; Kim, Kyubo; Jung, Wonguen; Shin, Kyung Hwan; Im, Seock-Ah; Kim, Hee-Jun; Kim, Yong Bae; Chang, Jee Suk; Choi, Doo Ho; Park, Yeon Hee; Kim, Dae Yong; Kim, Tae Hyun; Choi, Byung Ock; Lee, Sea-Won; Kim, Suzy; Kwon, Jeanny; Kang, Ki Mun; Chung, Woong-Ki; Kim, Kyung Su; Nam, Ji Ho; Yoon, Won Sup; Kim, Jin Hee; Cha, Jihye; Oh, Yoon Kyeong; Kim, In Ah Breast, Vol.49, pp.41-47	DOI
2020-02	PARP Inhibitors as Therapeutics: Beyond Modulation of PARylation Min, Ahrum; Im, Seock-Ah Cancers, Vol.12 No.2, p. 394	DOI

1 2 3 4 5 6 6